When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
XERS - Xeris Biopharma: Market Is Snubbing The Strongbridge Acquisition
Xeris Pharmaceuticals Inc.
Xeris Pharmaceuticals acquired Strongbridge Biopharma in a stock swap and contingent value rights transaction. The combined company is now called Xeris Biopharma Holdings.
Recorlev is ready for approval in Endogenous Cushing’s Syndrome. The FDA set the PDUFA date for January 1st of 2021. If Recorlev is approved, Xeris could have three products.
I lay out my plan for trading Xeris around Recorlev’s PDUFA.